A Tolerability and Pharmacokinetics Study of SHR6390 in Advanced Melanoma Patients
Clinical trial NCT02671513 · UNKNOWN
Trial details
- NCT number
- NCT02671513
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2016-11-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.